Douglas J. Langston
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Douglas J. Langston
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 23 | |
| Public Company | Apparel/Footwear Retail | 7 | |
Capital Title Group, Inc.
 Capital Title Group, Inc. Specialty InsuranceFinance Capital Title Group, Inc. provided escrow services and issued title insurance and property and casualty insurance. Its escrow services were performed for a variety of purchase, sale, financing, commercial and other transactions. It was headquartered in Scottsdale, AZ
1
| Extinct | Specialty Insurance | 1 |
College Loan Corp.
 College Loan Corp. Finance/Rental/LeasingFinance College Loan Corp. engages in the provision of loans for education. It finances student loans through the issuance of notes by various trusts. The company was founded by Cary Katz in September 1999 and is headquartered in Las Vegas, NV.
1
| Private Company | Finance/Rental/Leasing | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Douglas J. Langston
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer Sales & Marketing | |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| University of San Diego | College/University | Director/Board Member Masters Business Admin Undergraduate Degree | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Teva North America | Chief Executive Officer Director of Finance/CFO | ||
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
Calidi Biotherapeutics, Inc. (United States)
 Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | President Director/Board Member | |
| ALBANY MOLECULAR RESEARCH, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| University of California, Davis | College/University | Undergraduate Degree Corporate Officer/Principal | |
| San Diego State University | College/University | Undergraduate Degree Director/Board Member | |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| CALIDI BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Doctorate Degree Undergraduate Degree | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Nankai University | College/University | Undergraduate Degree Graduate Degree | |
| CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member | |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
| Celgene Global Health | Chief Executive Officer | ||
| BEYOND AIR, INC. | Medical Specialties | Director/Board Member | |
| Arthritis Foundation New Jersey Chapter | Director/Board Member | ||
| BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
| NEXGEL, INC. | Chemicals: Specialty | Director/Board Member | |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chairman | |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor | |
| Cebu Institute of Medicine | College/University | Undergraduate Degree | |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Undergraduate Degree | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
RetroSense Therapeutics LLC
 RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member | |
| METASTAT, INC. | Electrical Products | Chairman | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Biotechnology | Director/Board Member | |
| IR BIOSCIENCES HOLDINGS, INC. | Biotechnology | Director/Board Member | |
| Fudan University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 43 |
| China | 4 |
| Israel | 4 |
| Vereinigtes Königreich | 2 |
| Philippinen | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Process Industries | 2 |
| Finance | 2 |
Operativ
| Director/Board Member | 121 |
| Corporate Officer/Principal | 75 |
| Independent Dir/Board Member | 33 |
| Chief Executive Officer | 32 |
| President | 30 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jerome Zeldis | 38 |
| Cam Gallagher | 24 |
| M. Scott Salka | 20 |
| William S. Marth | 20 |
| Ernst-Günter Afting | 19 |
| George Ng | 17 |
| Vuong Trieu | 16 |
| Yue Wu | 16 |
| Ian Walters | 15 |
| Jeffrey Su | 15 |
| Mike A. Royal | 13 |
| Daniel J. Levitt | 13 |
| Richard Vincent | 13 |
| David Deming | 12 |
| Amar P. Singh | 11 |
- Börse
- Insiders
- Douglas J. Langston
- Unternehmensverbindungen
